Perfusion computed tomography for monitoring induction chemotherapy in patients with squamous cell carcinoma of the upper aerodigestive tract: Correlation between changes in tumor perfusion and tumor volume

Journal of Computer Assisted Tomography

Volumn 33, Issue 4, 2009, Pages 552-559

  Petralia, Giuseppe ^a   Preda, Lorenzo ^a   Giugliano, Gioacchino ^a   Jereczek Fossa, Barbara A ^a,b   Rocca, Andrea ^a   D'Andrea, Gabriele ^b   Holalkere, Nagaraj Setty ^c   Chiesa, Fausto ^a   Bellomi, Massimo ^a,b  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Chemotherapy; Monitoring; Perfusion CT; Tumor volume; Upper aerodigestive tract

Indexed keywords

BLOOD; COMPUTERIZED TOMOGRAPHY; HEMODYNAMICS; TUMORS;

BLOOD FLOW VOLUME; BLOOD VOLUMES; INDUCTION CHEMOTHERAPY; MEAN TRANSIT TIME; NORMAL TISSUE; PERFUSION CT; SQUAMOUS CELL CARCINOMA; TUMOR BLOOD FLOWS; TUMOR VOLUMES; UPPER AERODIGESTIVE TRACTS;

CHEMOTHERAPY;

CISPLATIN; FLUOROURACIL; IOMEPROL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD VOLUME; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CAPILLARY PERMEABILITY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; GASTROINTESTINAL CARCINOMA; HUMAN; HUMAN TISSUE; HYPOPHARYNX CARCINOMA; LARYNX CARCINOMA; MALE; MOUTH CARCINOMA; MULTIPLE CYCLE TREATMENT; MUSCLE PERFUSION; OROPHARYNX CARCINOMA; PATIENT MONITORING; PERMEABILITY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; STERNOCLEIDOMASTOID MUSCLE; TISSUE PERFUSION; TREATMENT RESPONSE; TUMOR BLOOD FLOW; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 68949101917     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/RCT.0b013e31818d446e     Document Type: Article

References (31)

1. Faivre S, Marti A, Rixe O, et al. Preoperative sequential chemotherapy in locally advanced squamous cell carcinoma of the head and neck. Head Neck. 2005;27:311Y319.
2. Collins SL, Weichselbaum RR, Dougherty M, et al. Head and neck. In: Abelloff MD, Armitage JO, Licher AS, et al, eds. Clinical Oncology. New York, NY: Churchill Livingstone; 1995:961Y1022.
3. Altundag O, Gullu I, Altundag K, et al. Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: results of single-center study of 45 patients. Head Neck. 2005;27:15Y21.
4. Kies MS. Induction chemotherapy for squamous cancer of the head and neck. Curr Oncol Rep. 9:129Y133.
5. Urba S,Wolf G, Eisbruch A, et al. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation:anewtreatmentparadigm.JClinOncol.2006;24:593Y598.
6. Kova'cs AF. Response to intraarterial induction chemotherapy: a prognostic parameter in oral and oropharyngeal cancer. Head Neck. 2006;28:678Y688.
7. Preda L, Lovati E, Chiesa F, et al. Measurement by multidetector CT scan of the volume of hypopharyngeal and laryngeal tumours: accuracy and reproducibility. Eur Radiol. 2007;17:2096Y2102.
8. Hermans R, Lambin P, Van der Goten A, et al. Tumoural perfusion as measured by dynamic computed tomography in head and neck carcinoma. Radiother Oncol. 1999;53:105Y111.
9. Gandhi D, Hoeffner EG, Carlos RC, et al. Computed tomography perfusion of squamous cell carcinoma of the upper aerodigestive tract. Initial results. J Comput Assist Tomogr. 2003;27:687Y693.
10. Gandhi D, Chepeha DB, Miller T, et al. Correlation between initial and early follow-up CT perfusion parameters with endoscopic tumor response in patients with advanced squamous cell carcinomas of the oropharynx treated with organ-preservation therapy. Am J Neuroradiol. 2006;27:101Y106.
11. Hermans R, Meijerink M, Van den Bogaert W, et al. Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy. Int J Radiat Oncol Biol Phys. 2003;57:1351Y1356.
12. Zima A, Carlos R, Gandhi D, et al. Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy? AJNR Am J Neuroradiol. 2007;28:328Y334.
13. Sobin LH, Wittekind CH. TNM Classification of Malignant Tumours. 6th ed. New York, NY: Wiley; 2002.
14. Lee TY, Purdie TG, Stewart E. CT imaging of angiogenesis. Q J Nucl Med. 2003;47:171Y187.
15. R Development Core Team, R Foundation for Statistical Computing, Vienna, Austria. R: a language and environment for statistical computing. Available at: http://www.R-project.org. Accessed April 2007.
16. Rumboldt Z, Al-Okaili R, Deveikis JP. Perfusion CT for head and neck tumors: pilot study. Am J Neuroradiol. 2005;26:1178Y1185.
17. Miles KA. Perfusion CT for the assessment of tumour vascularity: which protocol? Br J Radiol. 2003;76:S36YS42.
18. Goh V, Halligan S, Hugill JA, et al. Quantitative colorectal cancer perfusion measurement using dynamic contrast-enhanced multidetector-row computed tomography: effect of acquisition time and implications for protocols. J Comput Assist Tomogr. 2005;29:59Y63.
19. Kalra MK, Small WC, Torres WE. A 45-second CT perfusion protocol for rectal cancers may not be adequate to infer vascular permeability-surface area products. Radiology. 2006;238:755Y756.
20. Kremser C, Trieb TR, Judmaier W, et al. Assessing tumor perfusion and treatment response in rectal cancer. Radiology. 2006;238:756Y757.
21. Sahani D, Kalva S, Hahn PF. Response. Radiology. 2006;238:757.
22. Martin L, Lartigau L, Weeger P, et al. Changes in the oxygenation of head and neck tumors during carbogen breathing. Radiother Oncol. 1993;27:123Y130.
23. Bisdas S, Baghi M, Smolarz A, et al. Quantitative measurements of perfusionandpermeabilityoforopharyngealandoralcavitycancer, recurrent disease, and associated lymph nodes using first-pass contrast-enhanced computed tomography studies. Invest Radiol. 2007;42:172Y179.
24. Lennernas B, Albertsson P, Lennernas H, et al. Chemotherapy and antiangiogenesis-drug-specific, dose-related effects. Acta Oncol. 2003;42:294Y303.
25. Sahani D, Kalva S, Hamberg LM. Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations. Radiology. 2005;234:785Y792.
26. Belton AL, Saini S, Liebermann K, et al. Tumour size measurement in an oncology clinical trial: comparison between off-site and on-site measurements. Clin Radiol. 2003;58:311Y314.
27. Jaffe CC. Measures of response: RECIST, WHO, and new alternatives. J Clin Oncol. 2006;24:3245Y3251.
28. Döbert N, Kova'cs AF, Menzel C, et al. FDG uptake after intraarterial chemotherapy in head and neck cancer. Nuklearmedizin. 2006;45:243Y247.
29. Connell CA, Corry J, Milner AD, et al. Clinical impact of, and prognosticstratification by, F-18 FDG PET/CT in head and neck mucosalsquamous cell carcinoma. Head Neck. 2007;29:986Y995.
30. Döbert N, Kova'cs AF, Menzel C, et al. The prognostic value of FDG PET in head and neck cancer. Correlation with histopathology. Q J Nucl Med Mol Imaging. 2005;49:253Y257.
31. Bisdas S, Surlan-Popovic K, Didanovic V, et al. Functional CT of squamous cell carcinoma in the head and neck: repeatability of tumor and muscle quantitative measurements, inter-and intra-observer agreement. Eur Radiol. 2008;18:2241Y2250.